- Home
- WKHS vs ATRA Comparison
WKHS vs ATRA Comparison
Compare WKHS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | ATRA |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3M | 38.9M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WKHS | ATRA |
|---|---|---|
| Price | $3.09 | $9.23 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $5.00 |
| AVG Volume (30 Days) | ★ 75.7K | 52.0K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.92 | ★ 122.52 |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $120,772,000.00 |
| Revenue This Year | $89.23 | N/A |
| Revenue Next Year | $28.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $3.92 |
| 52 Week High | $11.80 | $19.15 |
Technical Indicators
Market Signals| Indicator | WKHS | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 54.73 |
| Support Level | $2.76 | $8.54 |
| Resistance Level | $3.50 | $9.11 |
| Average True Range (ATR) | 0.24 | 0.57 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 49.50 | 93.72 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).